China
Chinese cities grab $355m sovereign loan to revamp health infrastructure
This includes enhancing the treatment capacity of medical institutions to deal with epidemics.
Chinese cities grab $355m sovereign loan to revamp health infrastructure
This includes enhancing the treatment capacity of medical institutions to deal with epidemics.
Pandemic triggers reforms in China's healthcare
Only 10 community health centres in Wuhan were prepared to admit COVID-19 patients.
InterSystems TrakCare goes live in Amcare Women's and Children's Hospital, Baodao in Beijing despite coronavirus
As China grapples with the spread of COVID-19, many industries have been impacted, but none more so than the medical industry.
China's healthcare spending tipped to grow 12.6% to $926.8b in 2020
The government is expected to account for the majority of the spending.
Alibaba injects more assets into healthcare unit: report
The group's stake in Ali Health will rise to 59.5% from 56.6% as a result.
InterSystems releases Novel Coronavirus screening functionality for TrakCare®
Unified healthcare information system provider is quick to respond to help clinicians in China and multiple other countries screen and support patients with 2019-nCov.
China's API supply disruption worries pharma companies
A bulk of drug intermediates are sourced from China.
Ping An Good Doctor adds Thailand's BDMS to its overseas network
The company launched a video consultation service that connects users to Thai MDs.
OUE Lippo Healthcare, CMSK to co-develop Prince Bay hospital in China
It entered a share subscription agreement for $17.9m.
70 out of 119 new drugs in China get price cut of 60.7%
27 contract renewal drugs received a 26.5% average price cut.
Tencent's Medipedia draws tech-challenged seniors via rich storytelling
Medical content can be viewed in the form of articles, animation, and videos.
Chinese court dismisses Weixin claim against OUE Lippo
The Wuxi Xinwu District Court held that a 2015 land transfer between Wuxi Yilin and Wuxi New District Phoenix Hospital was legal.
Britain's AstraZeneca invests $1b in Chinese life sciences parks
It will also boost the headcount in its Shanghai R&D centre to 1,000.
Top Chinese drug distributors grapple with tepid margins
Blame the two-invoice system.
Chinese pharmas face price pressures from Indian entrants under GPO
The entrance of Indian players may cut prices further by 30%.
Chinese pharma sales to hit $268b by 2028: Fitch Solutions
The effects of regulatory change on the sales of patented medicine are expected to be mild.
VC-sourced healthcare funding in Asia fell 39% to $2.57b in Q2
China-based Weimai’s $155m funding round was one of the quarter’s notable deals.